Glen Weiss, MD, MBA

September 1, 2016

|

Estimated Read Time:

1–2 minutes

Glen Weiss, MD, MBA, was named 2016 Healthcare Leadership Awards’ Researcher of the Year by AZ Business magazine. Dr. Weiss is Director of Clinical Research, Director of Phase I and II Clinical Trials, Cancer Treatment Centers of America, Arizona, US, and is Clinical Associate Professor at University of Arizona College of Medicine.

About the Authors

Share this Article:

Glen Weiss, MD, MBA

Recent Posts

See You in Seoul: Inside WCLC 2026

Amazing Case Race Returns to WCLC 2026

Next Stop: Seoul and the 2026 World Conference on Lung Cancer

Challenge Accepted: Move, Connect, and Win Prizes in Seoul

COCOON’s Prophylactic Regimen Resulted in Decreased Incidence and Severity of Dermatologic-related Adverse Events

MARIPOSA OS Data Confirms Improved Efficacy for Amivantamab Plus Lazertinib in the First Line for EGFR-mutated NSCLC

Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection

Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy

Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC

No “Known” Risk Factors: The Health Consequences of Radiation Therapy

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging

No PFS, OS Benefit Seen in Final Results from PACIFIC-2

WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers

Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture

A Holistic Approach to Patient Care